KRAS G12C inhibitor 13
Product Specifications
UNSPSC Description
KRAS G12C inhibitor 13 is a KRAS G12C inhibitor extracted from patent WO2018143315A1, compound 30[1].
Target Antigen
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein;MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kras-g12c-inhibitor-13.html
Solubility
10 mM in DMSO
Smiles
C=CC(C(C1=C(C=NN2)C2=CC=C1C)=C3OCC(F)(F)F)=CC4=C3N=C(OC5CCN(C6CCOCC6)CC5)N=C4N7CCC8(CN(C(C=C)=O)C8)CC7
Molecular Weight
745.83
References & Citations
[1]KURAMOTO, Kazuyuki, et al. Quinazoline compound. WO2018143315A1.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-126292/KRAS-G12C-inhibitor-13-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-126292/
Clinical Information
No Development Reported
CAS Number
2241719-75-3
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
